These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37283345)

  • 1. Short-term adverse effects of COVID-19 vaccines after the first, second, and booster doses: a cross-sectional survey from Punjab, Pakistan, and the implications.
    Mustafa ZU; Maqbool F; Wahid M; Salman M; Haroon S; Khan YH; Mallhi TH; Godman B
    Rev Soc Bras Med Trop; 2023; 56():e0044. PubMed ID: 37283345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trajectory of COVID-19 vaccine hesitancy post-vaccination and public's intention to take booster vaccines: A cross-sectional analysis.
    Salman M; Mallhi TH; Khan YH; Mustafa ZU; Khan MT; Khan FU; Butt MH; Shehzadi N; Farrukh MJ; Waheed M; Azmat F; Saeed A; Mazhar SA; Ali A; Ashfaq A; Hussain K
    Hum Vaccin Immunother; 2023 Aug; 19(2):2225990. PubMed ID: 37350298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Vaccine Reactions After COVID-19 Vaccine Booster Doses Among Pregnant and Lactating Individuals.
    Kachikis A; Englund JA; Covelli I; Frank Y; Haghighi C; Singleton M; Drake AL; Eckert LO
    JAMA Netw Open; 2022 Sep; 5(9):e2230495. PubMed ID: 36074467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short Term Side Effects Of Inactivated COVID-19 Vaccines Among Pakistani Population: A Survey-Based Cross-Sectional Study.
    Nawaz Z; Zahid M; Sajjad M; Azhar N; Hasan NU; Siddiqui AS
    J Pak Med Assoc; 2023 Aug; 73(8):1592-1597. PubMed ID: 37697748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance of Side Effects after Two Doses of COVID-19 Vaccines among Patients with Comorbid Conditions: A Sub-Cohort Analysis from Saudi Arabia.
    Mallhi TH; Khan YH; Butt MH; Salman M; Tanveer N; Alotaibi NH; Alzarea AI; Alanazi AS
    Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Side effects after COVID-19 vaccinations among residents of Poland.
    Andrzejczak-Grządko S; Czudy Z; Donderska M
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4418-4421. PubMed ID: 34227078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the reported adverse effects of COVID-19 vaccines among vaccinated Arab populations: a multi-national survey study.
    Amer SA; Al-Zahrani A; Imam EA; Ishteiwy EM; Djelleb IF; Abdullh LR; Ballaj D; Amer YA; El-Sokkary RH; Elshabrawy AM; Eskander G; Shah J; Raza ML; ALsafa AMAA; Ali HT; Fawzy HM
    Sci Rep; 2024 Feb; 14(1):4785. PubMed ID: 38413637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A First Report on Side-Effects of COVID-19 Vaccines among General Population in Sudan: A Cross-Sectional Analysis.
    Mohamed MS; Mohamed AO; Alenazy R; Khan YH; Idriss MT; Alhudaib NAA; Elsaman T; Mohamed MA; Eltayib EM; Mallhi TH
    Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community.
    Abukhalil AD; Shatat SS; Abushehadeh RR; Al-Shami N; Naseef HA; Rabba A
    BMC Infect Dis; 2023 Jan; 23(1):5. PubMed ID: 36604613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial.
    Mallory RM; Formica N; Pfeiffer S; Wilkinson B; Marcheschi A; Albert G; McFall H; Robinson M; Plested JS; Zhu M; Cloney-Clark S; Zhou B; Chau G; Robertson A; Maciejewski S; Hammond HL; Baracco L; Logue J; Frieman MB; Smith G; Patel N; Glenn GM;
    Lancet Infect Dis; 2022 Nov; 22(11):1565-1576. PubMed ID: 35963274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study.
    Sridhar S; Joaquin A; Bonaparte MI; Bueso A; Chabanon AL; Chen A; Chicz RM; Diemert D; Essink BJ; Fu B; Grunenberg NA; Janosczyk H; Keefer MC; Rivera M DM; Meng Y; Michael NL; Munsiff SS; Ogbuagu O; Raabe VN; Severance R; Rivas E; Romanyak N; Rouphael NG; Schuerman L; Sher LD; Walsh SR; White J; von Barbier D; de Bruyn G; Canter R; Grillet MH; Keshtkar-Jahromi M; Koutsoukos M; Lopez D; Masotti R; Mendoza S; Moreau C; Ceregido MA; Ramirez S; Said A; Tavares-Da-Silva F; Shi J; Tong T; Treanor J; Diazgranados CA; Savarino S
    Lancet Infect Dis; 2022 May; 22(5):636-648. PubMed ID: 35090638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse effects following COVID-19 vaccination in Iran.
    Babaee E; Amirkafi A; Tehrani-Banihashemi A; SoleimanvandiAzar N; Eshrati B; Rampisheh Z; Asadi-Aliabadi M; Nojomi M
    BMC Infect Dis; 2022 May; 22(1):476. PubMed ID: 35585518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.
    Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD
    Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prevalence of Side Effects of Sinopharm COVID-19 Vaccine: An Experience From Pakistan.
    Haider T; Abidi SRZ; Fatima M; Zafar A; Siddiqui RQU; Khan W; Saeed T; Anwar A; Hashmi AA
    Cureus; 2023 Apr; 15(4):e38180. PubMed ID: 37252607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of post-vaccine side effects among COVID-19 immunized community of Southern Pakistan.
    Qureshi A; Syed Sulaiman SA; Rehman W; Mehmood A; Idrees S; Kumar N
    PLoS One; 2023; 18(5):e0285736. PubMed ID: 37220099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Cross-Sectional Study of Untoward Reactions Following Homologous and Heterologous COVID-19 Booster Immunizations in Recipients Seventeen Years of Age and Older.
    Tamburro M; Ripabelli G; D'Amico A; De Dona R; Iafigliola M; Parente A; Samprati N; Santagata A; Adesso C; Natale A; Di Palma MA; Cannizzaro F; Sammarco ML
    J Community Health; 2022 Oct; 47(5):814-821. PubMed ID: 35750980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine.
    Bookstein Peretz S; Regev N; Novick L; Nachshol M; Goffer E; Ben-David A; Asraf K; Doolman R; Levin EG; Regev Yochay G; Yinon Y
    Ultrasound Obstet Gynecol; 2021 Sep; 58(3):450-456. PubMed ID: 34198360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective evaluation of side-effects associated with the booster dose of Pfizer-BioNTech/BNT162b2 COVID-19 vaccine among females in Eastern Province, Saudi Arabia.
    Hassan YAM; Daud Ali M; Al-Eid RR; Al-Ghuraya FA; Essa Alqasimi Z; Ahmad A; Eltrafi Z; Ghosn SA
    Vaccine; 2022 Nov; 40(49):7087-7096. PubMed ID: 36404426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of AstraZeneca COVID-19 vaccine side effects among Nigist Eleni Mohammed memorial comprehensive specialized hospital health workers. Cross sectional survey.
    Desalegn M; Garoma G; Tamrat H; Desta A; Prakash A
    PLoS One; 2022; 17(6):e0265140. PubMed ID: 35749520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-reported side effects of COVID-19 vaccines among health professions students in India.
    Majumder MAA; Bharatha A; Kumar S; Chatterjee M; Gupta S; Harewood H; Singh K; Johnson W; Rajasundaram A; Dutta SB; Prasad SV; Rahman S; Kabir R; Parsa AD; Gaur U; Rabbi AMF; Krishnamurthy K; Mohammad S; Chode V; Haque M; Campbell MH
    PeerJ; 2024; 12():e17083. PubMed ID: 38590705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.